Influenza viral infections presentation, prevention, and treatment

Nurse Practitioner

Volumn 23, Issue 9, 1998, Pages 17-39

  Kennedy, Michelle M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; INFLUENZA VACCINE;

ANTIGENIC VARIATION; DRUG CONTRAINDICATION; HUMAN; INFLUENZA; MICROBIOLOGY; REVIEW; UNITED STATES;

ANTIGENIC VARIATION; ANTIVIRAL AGENTS; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; UNITED STATES;

EID: 0032160028     PISSN: 03611817     EISSN: 15388662     Source Type: Journal    
DOI: 10.1080/19986205-199809000-00003     Document Type: Article

References (35)

1. Smith CB: Influenza viruses. In: Gorbach JG, BartlettJG, Blacklow NR, eds. Infectious Disease, 4th ed. Philadelphia: W.B. Saunders Co.; 1992: 1740-45
2. Nichol KL, Lofgren RP, Gapinski J: Influenza vaccination: knowledge, at-titudes, and behavior among high-risk outpatients. Arch Intern Med 1992;152:106-10
3. Centers for Disease Control and Prevention: Update: influenza activity in the United States and worldwide, 1996-97 season, and composition of the 1997-98 influenza vaccine. MMWR 1997;40(15):325-30
4. Dolin R: Virai pneumonia. In: Wyngaarden JB, Smith L, Bennett JC, eds. Textbook of Medicine, 5th ed. Philadelphia: W.B. Saunders Co.; 1992:485-87
5. Centers for Disease Control and Prevention: Prevention and control of in-fluenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997;46(RR-9): 1-25
6. Marwick C: Selection of influenza strains for the 1997 vaccine. JAMA 1997;277(14):1103-04
7. Webster RG, Sharp GB, Claas EC: Interspecies transmission of influenza viruses. Am J Respir Crit Care Mcd 1995;152:S25-S30
8. Zhou N, He S, Zhang T, et al: Influenza infection in huinans and pigs in southcastem China. Arch Virol 1996;141:649-61
9. Morse SS: Patterns and predictability in emerging infections. Hosp Pract 1996;31(4):85-91,96-101
10. Dolin R: Influenza. In: Fauci AS, Braunwald E, Isselbacher KJ, eds. Harri-son’s Principies of Internal Medicine, 14th ed. New York: McGraw-Hill BookCo.1998:11 12-16
11. Centers for Disease Control and Prevention: Isolation of avian influenza A (H5N1) viruses from humans. MMWR 1998;46:1245-47
12. Oates JA, Wood AJ: Prophylaxis and treatment of influenza. N Engl J Med 1996;322(7):443-50
13. Moore G: Influenza and Parkinson’s disease. Public Health Rep 1972; 92(l):79-80
14. Sasco AJ, Paffenbargcr RS: Measles infection and Parkinson’s disease. Am J Epidemiol 1985;122(6): 1017-31
15. Fedson DS: Adult immunization: summary of the national vaccine advisory committee report.JAMA 1994;272(14): 1133-37
16. Williams WW, Hickson MA, Kane MA, et al: Immunization policies and vaccine coveragc among adults: the risk for missed opportunitics. Ann In-tem Med 1988;108(4):616-25
17. World Health Organization: Recommended composition of influenza virus vaccines for use in the 1997-1998 season. Weekly Epidemiological Record 1997;72:57-64
18. Palese P, Zavala F, Muster T, et al: Development of novel influenza virus vaccines and vectors. J Infect Dis 1997;176(Suppl 1):S45-S49
19. Wilson R: Influenza vaccination. Thorax 1994;49:1079-80
20. Hampson AW: Surveillance for pandemic influenza. J Infect Dis 1997; 176(Suppl 1):S8-S13
21. Kark JD, Lebiush M, Rannon L, et al: The antigenicity of whole virus ver-sus subunit trivalent influenza vaccines. Med Microbiol Immunol 1981;170:55-62
22. Centers for Disease Control and Prevention: Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immuniza-tion Practices (ACIP), MMWR 1998;47(RR-6)3-26
23. Centers for Disease Control and Prevention: Use of vaccines and immunc globulins in persons with altercd immunocompetence: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1993;42(RR-4):43-57
24. Glesby MJ, Hoover DR, Farzadegan H, et al: The effect of influenza vaccination on human immunodeficiency virus type 1 load: a randomized, double-blind, placebo-controlled study. J Infect Dis 1996;174:1332-36
25. Gill PW, Cunningham AL, Murphy AM. Should healthy children be vac-cinated against influenza? Lancet 1987;1:1440-41
26. Imperato PJ: A perspective on influenza control. Lancet 1986;1:728-30
27. Scholtissek C: Potential hazards associated with influenza virus vaccines. Dev Biol Stand 1995;84:55-58
28. Kaplan J: Guillain-Barre syndrome in the United States and lack of associ-ation with influenza vaccination. JAMA 1982;248(5):698-700
29. Gomolin IH, Leib HB, Arden NH, et al: Control of influenza outbreaks in nursing homes: guidelines for diagnosis and management. J Am Geriatr Soc 1995 j43(1):71-74
30. Nichol KL, Margolis KL, Lind A, et al: Side effects associated with influenza vaccination in healthy working adults: a randomized, placebo-controlled trial. Arch Intem Med 1996;156:1546-50
31. Patriarca PA: Influenza vaccination and warfarin or theophylline toxicity in nursing home residents. N EnglJ Mcd 1983;308(18):1601-04
32. Meridity CG: Effects of influenza virus vaccine on hepatic drug metabolism. Clin Pharmacol Ther 1985;37:396-401
33. Honkanen PO, Keistinen T, Kivela SL: Reactions following administra-tion of influenza vaccine alone or with pneumococcal vaccine to the el-derly. Arch Intem Med 1996;156:205-08
34. Centers for Disease Control and Prevention: Pneumococcal and influenza vaccination leveis among adults aged >65 years in the United States, 1993. MMWR 1996;45(40):853-59
35. Kilbourne ED: Inactivated influenza vaccines. In: Plotkin SA, Mortimer MA, eds. Vaccines, 2nd ed. Philadelphia: W.B. Saunders Co.;1994: 567-68